Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 18-Jun-24 5:00 PM View:  | Atea Pharmaceuticals, Inc. (AVIR) | 16-Jun-24 | Option Exercise | 33,150 | -- | -- | 4% 778.35K to 811.5K | |
| 26-Jan-24 4:39 PM View: | Rain Oncology Inc. (RAIN) | 26-Jan-24 | Disposition (change in control) | 1,005,210 | -- | -- | (100%) 1.01M to 0 | |
| 22-Nov-23 6:22 PM View: | Essa Pharma Inc. (EPIX) | 21-Nov-23 | Private Purchase | 23,259 | $5.73 | $133,274.00 | 3% 761.14K to 784.4K | |
| 16-Nov-23 5:45 PM View: | Essa Pharma Inc. (EPIX) | 03-Nov-23 | Purchase | 16,471 | $5.99 | $98,661.30 | 2% 744.4K to 760.88K | |
| 16-Nov-23 5:45 PM View: | Essa Pharma Inc. (EPIX) | 02-Nov-23 | Private Purchase | 60,000 | $5.35 | $321,000.00 | 9% 684.4K to 744.4K | |
| 05-Jan-23 3:41 PM View: | Essa Pharma Inc. (EPIX) | 21-Dec-22 | Sale | 72,223 | $2.41 | $174,401.00 | (10%) 756.63K to 684.4K | |
| 05-Jan-23 3:41 PM View: | Essa Pharma Inc. (EPIX) | 20-Dec-22 | Sale | 43,617 | $2.53 | $110,351.00 | (5%) 800.24K to 756.63K | |
| 05-Jan-23 3:41 PM View: | Essa Pharma Inc. (EPIX) | 16-Dec-22 | Sale | 50,000 | $2.67 | $133,500.00 | (6%) 850.24K to 800.24K | |
| 05-Jan-23 3:41 PM View: | Essa Pharma Inc. (EPIX) | 15-Dec-22 | Sale | 82,000 | $2.88 | $235,800.00 | (9%) 932.24K to 850.24K | |
| 05-Jan-23 3:41 PM View: | Essa Pharma Inc. (EPIX) | 14-Dec-22 | Sale | 25,000 | $3.00 | $75,000.00 | (3%) 957.24K to 932.24K | |
| 23-Nov-22 5:45 PM View: | Rain Oncology Inc. (RAIN) | 22-Nov-22 | Purchase | 77,000 | $8.27 | $636,790.00 | 8% 928.21K to 1.01M | |
| 23-Nov-22 5:45 PM View: | Rain Oncology Inc. (RAIN) | 21-Nov-22 | Private Purchase | 45,000 | $7.80 | $351,000.00 | 5% 883.21K to 928.21K | |
| 15-Nov-22 8:00 PM View: | Atea Pharmaceuticals, Inc. (AVIR) | 14-Nov-22 | Sale | 16,166 | $5.16 | $83,351.90 | (2%) 794.52K to 778.35K | |
| 15-Nov-22 8:00 PM View: | Atea Pharmaceuticals, Inc. (AVIR) | 11-Nov-22 | Sale | 25,500 | $5.15 | $131,333.00 | (3%) 820.02K to 794.52K | |
| 14-Nov-22 4:17 PM View: | Rain Oncology Inc. (RAIN) | 08-Nov-22 | Private Purchase | 42,881 | $5.83 | $249,996.00 | 5% 840.33K to 883.21K | |
| 22-Mar-22 5:45 PM View: | Kezar Life Sciences, Inc. (KZR) | 21-Mar-22 | Purchase | 20,000 | $14.77 | $295,400.00 | 2% 870.69K to 890.69K | |
| 22-Mar-22 5:45 PM View: | Kezar Life Sciences, Inc. (KZR) | 18-Mar-22 | Purchase | 60,000 | $16.74 | $1,004,400.00 | 7% 810.69K to 870.69K | |
| 23-Sep-21 10:00 PM View: | Kezar Life Sciences, Inc. (KZR) | 22-Sep-21 | Option Exercise | 8,896 | $5.60 | $49,817.60 | 1% 801.79K to 810.69K | |
| 23-Sep-21 10:00 PM View: | Kezar Life Sciences, Inc. (KZR) | 21-Sep-21 | Option Exercise | 17,792 | $6.77 | $120,452.00 | 2% 784.0K to 801.79K | |
| 23-Sep-21 10:00 PM View: | Rain Oncology Inc. (RAIN) | 21-Sep-21 | Market Purchase | 3,786 | $14.30 | $54,139.80 | < 1% 836.54K to 840.33K | 5% |
| 27-Apr-21 5:05 PM View: | Rain Oncology Inc. (RAIN) | 27-Apr-21 | Conversion | 711,540 | -- | -- | 569% 125.0K to 836.54K | |
| 27-Apr-21 5:05 PM View: | Rain Oncology Inc. (RAIN) | 23-Apr-21 | Purchase | 125,000 | $16.95 | $2,118,900.00 | 100% 0 to 125.0K | |
| 19-Apr-21 7:42 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 16-Apr-21 | Disposition | 5,000 | $38.00 | $190,000.00 | (100%) 5.0K to 0 | 0% |
| 04-Mar-21 6:47 PM View: | Essa Pharma Inc. (EPIX) | 22-Feb-21 | Market Purchase | 57,000 | $27.00 | $1,539,000.00 | 6% 900.24K to 957.24K | < 1% |
| 11-Jan-21 4:42 PM View: | Essa Pharma Inc. (EPIX) | 03-Dec-20 | Option Exercise | 42,207 | $3.64 | $153,701.00 | 5% 858.04K to 900.24K | |
| 03-Nov-20 8:09 PM View: | Atea Pharmaceuticals, Inc. (AVIR) | 03-Nov-20 | Conversion | 759,606 | -- | -- | 4052% 18.75K to 778.35K | |
| 03-Nov-20 8:09 PM View: | Atea Pharmaceuticals, Inc. (AVIR) | 03-Nov-20 | Purchase | 41,666 | $24.00 | $999,984.00 | 5% 778.35K to 820.02K | |
| 11-Jun-20 6:29 PM View: | Kezar Life Sciences, Inc. (KZR) | 11-Jun-20 | Market Purchase | 100,000 | $5.50 | $550,000.00 | 15% 684.0K to 784.0K | 1% |
| 05-Feb-20 8:15 PM View: | Kezar Life Sciences, Inc. (KZR) | 04-Feb-20 | Private Purchase | 120,846 | $2.60 | $314,200.00 | 21% 563.16K to 684.0K | |
| 04-Dec-19 6:28 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 03-Dec-19 | Market Sale | 47,890 | $4.00 | $191,560.00 | (91%) 52.89K to 5.0K | (846%) |
| 04-Dec-19 6:28 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 02-Dec-19 | Market Sale | 32,090 | $3.92 | $125,793.00 | (38%) 84.98K to 52.89K | (865%) |
| 24-Jun-19 4:45 PM View: | Atreca, Inc. (BCEL) | 24-Jun-19 | Conversion | 75,315 | -- | -- | 335% 22.49K to 97.81K | |
| 04-Apr-19 5:24 PM View: | Immune Design Corp. (IMDZ) | 02-Apr-19 | Disposition | 75,000 | $5.85 | $438,750.00 | (100%) 75.0K to 0 | 0% |
| 26-Oct-18 4:16 PM View: | Kineta, Inc./de (KA) | 26-Oct-18 | Market Purchase | 40,000 | $6.75 | $270,000.00 | 15% 266.16K to 306.16K | (83%) |
| 27-Jun-18 4:47 PM View: | Kezar Life Sciences, Inc. (KZR) | 25-Jun-18 | Conversion | 459,983 | -- | -- | 865% 53.17K to 513.16K | |
| 27-Jun-18 4:47 PM View: | Kezar Life Sciences, Inc. (KZR) | 25-Jun-18 | Purchase | 50,000 | $15.00 | $750,000.00 | 10% 513.16K to 563.16K | |
| 19-Dec-17 8:46 AM View: | Kineta, Inc./de (KA) | 18-Dec-17 | Market Purchase | 60,000 | $5.00 | $300,000.00 | 29% 206.16K to 266.16K | (77%) |
| 01-Nov-17 6:10 PM View: | Immune Design Corp. (IMDZ) | 30-Oct-17 | Market Purchase | 25,000 | $4.57 | $114,375.00 | 50% 50.0K to 75.0K | (68%) |
| 26-Oct-17 7:31 PM View: | Immune Design Corp. (IMDZ) | 25-Oct-17 | Market Purchase | 25,000 | $4.26 | $106,620.00 | 100% 25.0K to 50.0K | (66%) |
| 21-Apr-17 5:37 PM View: | Forte Biosciences, Inc. (FBRX) | 19-Apr-17 | Acquisition (other) | 25,335 | $10.00 | $253,350.00 | 100% 0 to 25.34K | |
| 20-Dec-16 6:43 PM View: | Immune Design Corp. (IMDZ) | 16-Dec-16 | Market Sale | 50,000 | $6.55 | $327,330.00 | (67%) 75.0K to 25.0K | 78% |
| 19-Dec-16 5:22 PM View: | Kineta, Inc./de (KA) | 16-Dec-16 | Market Purchase | 14,000 | $11.52 | $161,342.00 | 7% 192.16K to 206.16K | (91%) |
| 19-Dec-16 5:22 PM View: | Kineta, Inc./de (KA) | 15-Dec-16 | Market Purchase | 26,000 | $10.99 | $285,626.00 | 16% 166.16K to 192.16K | (90%) |
| 15-Sep-16 4:15 PM View: | Kineta, Inc./de (KA) | 14-Sep-16 | Market Purchase | 69,230 | $13.00 | $899,990.00 | 71% 96.93K to 166.16K | (92%) |
| 26-Apr-16 7:26 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 22-Apr-16 | Market Purchase | 5,000 | $49.47 | $247,340.00 | 6% 79.98K to 84.98K | (23%) |
| 21-Apr-16 12:20 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 19-Apr-16 | Market Purchase | 6,090 | $47.06 | $286,607.00 | 8% 73.89K to 79.98K | (20%) |
| 17-Feb-16 6:46 PM View: | Kineta, Inc./de (KA) | 17-Feb-16 | Conversion | 71,932 | -- | -- | 100% 0 to 71.93K | |
| 17-Feb-16 6:46 PM View: | Kineta, Inc./de (KA) | 17-Feb-16 | Purchase | 25,000 | $8.00 | $200,000.00 | 35% 71.93K to 96.93K | |
| 24-Sep-15 5:03 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 22-Sep-15 | Option Exercise | 12,500 | $12.70 | $158,750.00 | 20% 61.39K to 73.89K | |
| 04-Sep-15 4:57 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 02-Sep-15 | Option Exercise | 8,130 | $7.88 | $64,023.80 | 15% 53.26K to 61.39K |